Molecular imaging of adrenal neoplasms
Identifieur interne : 001E17 ( Main/Exploration ); précédent : 001E16; suivant : 001E18Molecular imaging of adrenal neoplasms
Auteurs : Clara C. Chen [États-Unis] ; Jorge A. Carrasquillo [États-Unis]Source :
- Journal of Surgical Oncology [ 0022-4790 ] ; 2012-10-01.
English descriptors
- Teeft :
- Adenoma, Adrenal, Adrenal glands, Adrenal incidentalomas, Adrenal lesions, Adrenal masses, Adrenal neoplasms, Adrenal tumors, Adrenocortical, Adrenocortical carcinoma, Adrenocortical tumors, Analog, Anatomic imaging, Benign, Benign disease, Benign lesions, Cancer patients, Carcinoma, Carrasquillo, Clin, Clin endocrinol metab, Clin oncol, Endocrinol, Fdopa, High sensitivity, Higher sensitivity, Highest sensitivity, Imaging, Important role, Intense uptake, Lesion, Lesion basis, Localization, Lung cancer, Malignancy, Malignant, Malignant disease, Malignant lesions, Metab, Metaiodobenzylguanidine, Metaiodobenzylguanidine scintigraphy, Metastasis, Metastatic, Metastatic disease, Metastatic pheochromocytoma, Mibg, Mibg imaging, Neoplasm, Neuroblastoma, Neuroendocrine, Neuroendocrine tumors, Nucl, Oncol, Oncology, Patient basis, Pentetreotide, Pheo, Pheochromocytoma, Positron, Positron emission tomography, Primary tumor, Prognostic, Prognostic implications, Radiology, Reagent, Receptor, Scintigraphy, Sdhb, Several studies, Shulkin, Somatostatin, Somatostatin receptors, Surg oncol, Surgical, Surgical oncology, Suvmax, Tomography, Transporter, Tumor detection, Uorodeoxyglucose positron emission tomography, Uptake.
Abstract
The adrenal glands are complex structures from which a variety of benign and malignant tumors may arise and are a common site of metastatic disease. Several radiopharmaceuticals are used for imaging the adrenals, including I‐123/I‐131 metaiodobenzylguanidine (MIBG), norcholesterol derivatives, In‐111 pentetreotide and Ga‐68 somatostatin analogs, [F‐18]fluorodeoxyglucose, [F‐18]fluorodopa, [F‐18]fluorodopamine, C‐11 meta hydroxyephedrine, and C‐11/F‐18/I‐123 Metomidate (MTO) or its analogs. In this review we focus on the role of these reagents in metastatic lesions, cortical neoplasms, pheochromocytoma/paraganglioma, and neuroblastoma (NB). J. Surg. Oncol. 2012; 106:532–542. © 2012 Wiley Periodicals, Inc.
Url:
DOI: 10.1002/jso.23162
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001D96
- to stream Istex, to step Curation: 001D73
- to stream Istex, to step Checkpoint: 000406
- to stream Main, to step Merge: 001E36
- to stream Main, to step Curation: 001E17
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Molecular imaging of adrenal neoplasms</title>
<author><name sortKey="Chen, Clara C" sort="Chen, Clara C" uniqKey="Chen C" first="Clara C." last="Chen">Clara C. Chen</name>
</author>
<author><name sortKey="Carrasquillo, Jorge A" sort="Carrasquillo, Jorge A" uniqKey="Carrasquillo J" first="Jorge A." last="Carrasquillo">Jorge A. Carrasquillo</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:8123635C4D047E6FAFE5FCFE21CD1D2EBE6595A1</idno>
<date when="2012" year="2012">2012</date>
<idno type="doi">10.1002/jso.23162</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-C1NZCMX8-0/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001D96</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001D96</idno>
<idno type="wicri:Area/Istex/Curation">001D73</idno>
<idno type="wicri:Area/Istex/Checkpoint">000406</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000406</idno>
<idno type="wicri:doubleKey">0022-4790:2012:Chen C:molecular:imaging:of</idno>
<idno type="wicri:Area/Main/Merge">001E36</idno>
<idno type="wicri:Area/Main/Curation">001E17</idno>
<idno type="wicri:Area/Main/Exploration">001E17</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Molecular imaging of adrenal neoplasms<ref type="note" target="#fn1"></ref>
</title>
<author><name sortKey="Chen, Clara C" sort="Chen, Clara C" uniqKey="Chen C" first="Clara C." last="Chen">Clara C. Chen</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Division of Nuclear Medicine, Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Carrasquillo, Jorge A" sort="Carrasquillo, Jorge A" uniqKey="Carrasquillo J" first="Jorge A." last="Carrasquillo">Jorge A. Carrasquillo</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan‐Kettering Cancer Center, New York</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Radiology, Weill Cornell Medical Center, New York</wicri:cityArea>
</affiliation>
<affiliation></affiliation>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Correspondence address: Professor Radiology, 1275 York Avenue New York</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Journal of Surgical Oncology</title>
<title level="j" type="sub">Seminars in Surgical Oncology: Adrenal</title>
<title level="j" type="alt">JOURNAL OF SURGICAL ONCOLOGY</title>
<idno type="ISSN">0022-4790</idno>
<idno type="eISSN">1096-9098</idno>
<imprint><biblScope unit="vol">106</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="532">532</biblScope>
<biblScope unit="page" to="542">542</biblScope>
<biblScope unit="page-count">11</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2012-10-01">2012-10-01</date>
</imprint>
<idno type="ISSN">0022-4790</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0022-4790</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Adenoma</term>
<term>Adrenal</term>
<term>Adrenal glands</term>
<term>Adrenal incidentalomas</term>
<term>Adrenal lesions</term>
<term>Adrenal masses</term>
<term>Adrenal neoplasms</term>
<term>Adrenal tumors</term>
<term>Adrenocortical</term>
<term>Adrenocortical carcinoma</term>
<term>Adrenocortical tumors</term>
<term>Analog</term>
<term>Anatomic imaging</term>
<term>Benign</term>
<term>Benign disease</term>
<term>Benign lesions</term>
<term>Cancer patients</term>
<term>Carcinoma</term>
<term>Carrasquillo</term>
<term>Clin</term>
<term>Clin endocrinol metab</term>
<term>Clin oncol</term>
<term>Endocrinol</term>
<term>Fdopa</term>
<term>High sensitivity</term>
<term>Higher sensitivity</term>
<term>Highest sensitivity</term>
<term>Imaging</term>
<term>Important role</term>
<term>Intense uptake</term>
<term>Lesion</term>
<term>Lesion basis</term>
<term>Localization</term>
<term>Lung cancer</term>
<term>Malignancy</term>
<term>Malignant</term>
<term>Malignant disease</term>
<term>Malignant lesions</term>
<term>Metab</term>
<term>Metaiodobenzylguanidine</term>
<term>Metaiodobenzylguanidine scintigraphy</term>
<term>Metastasis</term>
<term>Metastatic</term>
<term>Metastatic disease</term>
<term>Metastatic pheochromocytoma</term>
<term>Mibg</term>
<term>Mibg imaging</term>
<term>Neoplasm</term>
<term>Neuroblastoma</term>
<term>Neuroendocrine</term>
<term>Neuroendocrine tumors</term>
<term>Nucl</term>
<term>Oncol</term>
<term>Oncology</term>
<term>Patient basis</term>
<term>Pentetreotide</term>
<term>Pheo</term>
<term>Pheochromocytoma</term>
<term>Positron</term>
<term>Positron emission tomography</term>
<term>Primary tumor</term>
<term>Prognostic</term>
<term>Prognostic implications</term>
<term>Radiology</term>
<term>Reagent</term>
<term>Receptor</term>
<term>Scintigraphy</term>
<term>Sdhb</term>
<term>Several studies</term>
<term>Shulkin</term>
<term>Somatostatin</term>
<term>Somatostatin receptors</term>
<term>Surg oncol</term>
<term>Surgical</term>
<term>Surgical oncology</term>
<term>Suvmax</term>
<term>Tomography</term>
<term>Transporter</term>
<term>Tumor detection</term>
<term>Uorodeoxyglucose positron emission tomography</term>
<term>Uptake</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The adrenal glands are complex structures from which a variety of benign and malignant tumors may arise and are a common site of metastatic disease. Several radiopharmaceuticals are used for imaging the adrenals, including I‐123/I‐131 metaiodobenzylguanidine (MIBG), norcholesterol derivatives, In‐111 pentetreotide and Ga‐68 somatostatin analogs, [F‐18]fluorodeoxyglucose, [F‐18]fluorodopa, [F‐18]fluorodopamine, C‐11 meta hydroxyephedrine, and C‐11/F‐18/I‐123 Metomidate (MTO) or its analogs. In this review we focus on the role of these reagents in metastatic lesions, cortical neoplasms, pheochromocytoma/paraganglioma, and neuroblastoma (NB). J. Surg. Oncol. 2012; 106:532–542. © 2012 Wiley Periodicals, Inc.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Maryland</li>
<li>État de New York</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Maryland"><name sortKey="Chen, Clara C" sort="Chen, Clara C" uniqKey="Chen C" first="Clara C." last="Chen">Clara C. Chen</name>
</region>
<name sortKey="Carrasquillo, Jorge A" sort="Carrasquillo, Jorge A" uniqKey="Carrasquillo J" first="Jorge A." last="Carrasquillo">Jorge A. Carrasquillo</name>
<name sortKey="Carrasquillo, Jorge A" sort="Carrasquillo, Jorge A" uniqKey="Carrasquillo J" first="Jorge A." last="Carrasquillo">Jorge A. Carrasquillo</name>
<name sortKey="Carrasquillo, Jorge A" sort="Carrasquillo, Jorge A" uniqKey="Carrasquillo J" first="Jorge A." last="Carrasquillo">Jorge A. Carrasquillo</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Lorraine/explor/InforLorV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E17 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001E17 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Lorraine |area= InforLorV4 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:8123635C4D047E6FAFE5FCFE21CD1D2EBE6595A1 |texte= Molecular imaging of adrenal neoplasms }}
This area was generated with Dilib version V0.6.33. |